aTyr Pharma Equity 2024

aTyr Pharma Equity

90.66 M USD

aTyr Pharma Dividend yield

Ticker

LIFE

ISIN

US0021202025

WKN

A2PM86

In 2024, aTyr Pharma's equity was 90.66 M USD, a 26.79% increase from the 71.5 M USD equity in the previous year.

aTyr Pharma Aktienanalyse

What does aTyr Pharma do?

aTyr Pharma Inc is a biotechnology company based in San Diego, California. Founded in 2005, the company has gained a lot of attention in recent years for its focus on developing drugs based on proteomics, the analysis of proteins. The idea for aTyr came from the realization that there are a variety of proteins that can be used as a basis for developing new drugs. The company has developed a unique proteomics platform that allows for the identification and utilization of previously undiscovered proteins to understand biological processes and develop new drugs for diseases. aTyr specializes in the discovery and development of proteins associated with rare but difficult-to-treat diseases. This includes rare muscle diseases and lung diseases. The company collaborates closely with clinicians and scientists to advance its research and development. aTyr's business model is based on the development of new drugs based on proteomics, with a focus on rare diseases that are often neglected. The goal is to improve the quality of life for patients by developing new and innovative drugs. aTyr has various divisions, including therapeutic proteins and diagnostics. The company has a number of drugs in development targeting different diseases. This includes Resolaris, a protein focused on rare muscle diseases, and ATYR1923, developed for the treatment of lung diseases. Resolaris is a novel protein targeting rare muscle diseases such as FSHD and LGMD. It is currently being tested in clinical trials and has the potential to significantly improve the quality of life for patients with these severe conditions. The company is also developing ATYR1923, a protein for the treatment of lung diseases such as idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Overall, aTyr Pharma is an innovative company focused on the development of novel drugs based on proteomics. With its unique proteomics platform, the company has the potential to identify and utilize previously undiscovered proteins to understand biological processes and develop new drugs for diseases. With its various divisions, including therapeutic proteins and diagnostics, the company has the potential to improve the treatment of rare and difficult-to-treat diseases and enhance the lives of patients worldwide. aTyr Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing aTyr Pharma's Equity

aTyr Pharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding aTyr Pharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating aTyr Pharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

aTyr Pharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in aTyr Pharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about aTyr Pharma Stock

What is the equity of aTyr Pharma this year?

aTyr Pharma has equity of 90.66 M USD this year.

What was the equity of aTyr Pharma compared to the previous year?

The equity of aTyr Pharma has increased/decreased by 26.79% increased compared to the previous year.

What impact does a high equity have on investors of aTyr Pharma?

A high equity is advantageous for investors of aTyr Pharma as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of aTyr Pharma?

A low equity can be a risk for investors of aTyr Pharma, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of aTyr Pharma affect the company?

An increase in equity of aTyr Pharma can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of aTyr Pharma affect the company?

A reduction in equity of aTyr Pharma can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of aTyr Pharma?

Some factors that can affect the equity of aTyr Pharma include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of aTyr Pharma so important for investors?

The equity of aTyr Pharma is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can aTyr Pharma take to change the equity?

To change equity, aTyr Pharma can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does aTyr Pharma pay?

Over the past 12 months, aTyr Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, aTyr Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of aTyr Pharma?

The current dividend yield of aTyr Pharma is .

When does aTyr Pharma pay dividends?

aTyr Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of aTyr Pharma?

aTyr Pharma paid dividends every year for the past 0 years.

What is the dividend of aTyr Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is aTyr Pharma located?

aTyr Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von aTyr Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of aTyr Pharma from 3/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/29/2024.

When did aTyr Pharma pay the last dividend?

The last dividend was paid out on 3/29/2024.

What was the dividend of aTyr Pharma in the year 2023?

In the year 2023, aTyr Pharma distributed 0 USD as dividends.

In which currency does aTyr Pharma pay out the dividend?

The dividends of aTyr Pharma are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The aTyr Pharma stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von aTyr Pharma

Our stock analysis for aTyr Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of aTyr Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.